These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18923807)

  • 1. LRRK2 P755L variant in sporadic Parkinson's disease.
    Tomiyama H; Mizuta I; Li Y; Funayama M; Yoshino H; Li L; Murata M; Yamamoto M; Kubo SI; Mizuno Y; Toda T; Hattori N
    J Hum Genet; 2008; 53(11-12):1012-1015. PubMed ID: 18923807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of LRRK2 P755L variant in Parkinson's disease.
    Tan EK; Lim HQ; Yuen Y; Zhao Y
    Mov Disord; 2008 Apr; 23(5):734-6. PubMed ID: 18265005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease.
    Deng H; Le W; Huang M; Xie W; Pan T; Jankovic J
    Neurosci Lett; 2007 May; 419(2):104-7. PubMed ID: 17482357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
    Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
    Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.
    Skipper L; Li Y; Bonnard C; Pavanni R; Yih Y; Chua E; Sung WK; Tan L; Wong MC; Tan EK; Liu J
    Hum Mol Genet; 2005 Dec; 14(23):3549-56. PubMed ID: 16269443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    An XK; Peng R; Li T; Burgunder JM; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Zhang ZJ
    Eur J Neurol; 2008 Mar; 15(3):301-5. PubMed ID: 18201193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 Pro755Leu variant in ethnic Chinese population with Parkinson's disease.
    Yao LY; Guo JF; Wang L; Yu RH; Sun QY; Pan Q; Xia K; Tang BS; Shen L
    Neurosci Lett; 2011 May; 495(1):35-8. PubMed ID: 21406209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V
    Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
    Pulkes T; Papsing C; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1018-21. PubMed ID: 24997548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
    Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
    Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
    Hatano T; Funayama M; Kubo SI; Mata IF; Oji Y; Mori A; Zabetian CP; Waldherr SM; Yoshino H; Oyama G; Shimo Y; Fujimoto KI; Oshima H; Kunii Y; Yabe H; Mizuno Y; Hattori N
    Neurobiol Aging; 2014 Nov; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.